Navigation Links
Surgery Viable for Advanced Prostate Cancer, Study Finds
Date:5/17/2011

TUESDAY, May 17 (HealthDay News) -- Surgery to remove the prostate gland (radical prostatectomy) led to a 20-year survival rate for 80 percent of patients with advanced prostate cancer, a new study finds.

The study included patients with cancer that had spread beyond the prostate, known as cT3 prostate cancer, and underwent radical prostatectomy between 1987 and 1997.

The 80 percent survival rate in these patients compares to a 90 percent survival rate at 20 years for patients with cancer confined to the prostate (cT2 prostate cancer), the Mayo Clinic researchers said.

Previously, patients with cT3 prostate cancer were offered radiation or hormone treatment, but not radical prostatectomy, the study authors noted in a Mayo news release.

"We are doing a much better job of identifying and expanding candidates for surgery, which results in better, longer outcomes for so many of our patients," Dr. R. Jeffrey Karnes, of the department of urology, said in the news release.

The study was slated for presentation May 15 at the annual meeting of the American Urological Association, in Washington, D.C. Research presented at meetings is considered preliminary until it is published in a peer-reviewed journal.

More information

The American Cancer Society has more about prostate cancer.

-- Robert Preidt

SOURCE: Mayo Clinic, news release, May 15, 2011


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1

Related medicine news :

1. Obese People at Higher Risk of Infection After Colon Surgery
2. Advanced-stage prostate cancer patients experience 20-year survival rates with surgery
3. Brain Surgery for Mary Tyler Moore to Remove Benign Tumor
4. Synthetic mesh can improve outcome of prolapse surgery
5. Vaginal Mesh Surgery Effective for Bladder Prolapse Repair: Report
6. Weight-Loss Surgery Seems No Riskier for Seniors
7. Stem cell technology used in unique surgery
8. Surgery May Beat Antibiotics for Appendicitis, Study Finds
9. Surgery reduces risk of mortality due to prostate cancer even for low-risk groups
10. Heart Bypass Surgery Rates Drop Dramatically, Study Finds
11. Low-dose chest CT effective in reducing radiation for evaluation of cardiothoracic surgery patients
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Surgery Viable for Advanced Prostate Cancer, Study Finds
(Date:9/26/2017)... MA (PRWEB) , ... September 26, 2017 , ... CGL ... its first office under its new umbrella, CGL Technologies, LLC. , The new CGL ... industry veterans Remo Patitucci and Jon McCormack, both of whom have creative business development ...
(Date:9/26/2017)... Church, VA (PRWEB) , ... September 26, 2017 , ... ... and Cerulean Associates LLC **, Dec. 5-6, 2017 – Arlington, VA, http://www.fdanews.com/fdadataintegrity ... investigators: “If initial findings indicate the firm’s electronic records may not be trustworthy and ...
(Date:9/26/2017)... ... September 26, 2017 , ... DETECTO has been ... 1, 2017, the new agreement allows Premier members, at their discretion, to take ... “DETECTO is pleased to renew our agreement with Premier to be able to ...
(Date:9/26/2017)... ... September 26, 2017 , ... “Sound of My Song”: ... the creation of published author, Karmen Worden, a retired teacher with a passion for ... book is an intriguing and inspiring story on loss, living with depression, and finding ...
(Date:9/26/2017)... ... ... Saves Boobie and Ceebie”: a tool families can use to teach children about the love ... author, G.S. White, a devoted follower of Jesus Chris who is married with one son. ... not only for children but also to glorified God in everything he does.” --G.S. White ...
Breaking Medicine News(10 mins):
(Date:9/6/2017)... 2017  Robert G. Szewc, M.D., is recognized by ... recognition of his contributions to the Medical field.      ... at the practice of Kidney and Hypertension Specialists, which ... hypertension solutions. He has worked in this position since ... as well as expertise in kidneys, hypertension, chronic disease ...
(Date:9/6/2017)... 2017 NeuroRx, a clinical stage biopharma company developing ... (ASIB), has been granted Fast Track status by the US ... (ketamine HCl) followed by NRX-101 (D-cycloserine + lurasidone). The company ... this sequential therapy targeting patients who are admitted to Emergency ... ...
(Date:9/5/2017)... another milestone in their continued growth and success of the company.  Xyntek has ... engagements regionally.  ... at 318 West Adams Street, Suite 1528, Chicago, IL ... Xyntek's recently opened Midwest office will support the ... In addition to Xyntek,s headquarters ...
Breaking Medicine Technology: